-
Cabazitaxel (XRP6258) Practical Workflow
2026-09-02
Cabazitaxel (XRP6258) provides a research compound for evaluating microtubule dynamics disruption in taxane-resistant and P-glycoprotein-expressing cancer models. It is suitable for DMSO- or ethanol-based workflows, but it is insoluble in water and solutions should not be stored long term.
-
GmMKK4–GmMPK6–GmERF113 Signaling in Soybean Defense
2026-09-02
Gao and colleagues identify a phosphorylation-dependent GmMKK4–GmMPK6–GmERF113 cascade that links pathogen perception to transcriptional defense in soybean. Their genetic, biochemical, and transcriptional evidence shows that GmMPK6 activation improves resistance to Phytophthora sojae by stabilizing and activating GmERF113, providing a mechanistic framework for soybean disease-resistance research.
-
Merbromin Inhibits SARS-CoV-2 3CLpro
2026-09-01
Chen and colleagues identified merbromin as a selective mixed-type inhibitor of the SARS-CoV-2 main protease, 3CLpro, through activity-based screening of approximately 6,000 compounds. Kinetic, binding, and docking results suggest that merbromin engages two protease-associated binding sites, providing a mechanistic starting point for inhibitor optimization while remaining an in vitro finding.
-
IPA-3 in Mechanistic Kinase and Entry Assays
2026-09-01
IPA-3 is a non-ATP-competitive Pak1 inhibitor with value beyond routine kinase profiling. This article explains how its negative result in grass carp reovirus entry experiments can improve pathway controls, assay interpretation, and translational study design.
-
N2-Alkyl-dG Lesions and R-Loop Accumulation
2026-08-31
The 2024 Nucleic Acids Research study by Wang and colleagues identifies a direct connection between minor-groove N2-alkyl-dG DNA lesions and abnormal R-loop accumulation. By combining fluorescence microscopy, R-loop sequencing, transcriptional assays, and genetic depletion of the R-loop helicase DDX23, the work links chemically modified guanine to transcriptional obstruction and genome instability.
-
Dacomitinib and Mitochondrial Ferroptosis
2026-08-31
Dacomitinib (PF-00299804) is an irreversible pan-HER inhibitor with a useful role in dissecting how ErbB signaling intersects with mitochondrial ferroptosis defenses. This article translates METTL17 research into a practical, hypothesis-driven assay framework while separating established pharmacology from unvalidated cross-cancer applications.
-
Exendin-4 Workflows for Type 2 Diabetes Research
2026-08-30
Exendin-4 (Exenatide) supports controlled studies of cAMP signaling, glucose-induced insulin secretion, and beta cell performance. This practical guide combines concentration planning, assay workflows, stable yeast-expression insights, and troubleshooting for translational type 2 diabetes research.
-
Biodegradable Polyesters for VEGF mRNA Delivery
2026-08-29
The reference study develops three-armed biodegradable polyesters that combine cationic mRNA-complexing behavior with ester-based degradability and, in one formulation, reactive oxygen species scavenging and nitric oxide release. In a critical limb ischemia model, arginine-functionalized polyester nanoparticles improved VEGF mRNA delivery while also supporting an angiogenic and vascular microenvironment, although broader safety and translational studies remain necessary.
-
CCG-1423: RhoA Inhibitor Mechanism & Workflow
2026-08-28
CCG-1423 is a research-use RhoA inhibitor that suppresses MRTF-A nuclear import by disrupting its interaction with importin α/β1. Its documented applications include cancer research, invasion studies, apoptosis assays, and mechanistic analysis of RhoA transcriptional signaling, while direct antiviral activity remains unestablished.
-
Exercise, Muscle EVs, and Microglial Aβ Clearance
2026-08-28
This study identifies skeletal muscle-derived extracellular vesicles as a mechanistic link between swimming exercise and improved cognition in Alzheimer’s disease mice. Its results connect the vesicular miR-378a-3p–p110α pathway to disease-associated microglial function and amyloid-β plaque clearance, suggesting an exercise-mimicking strategy for preclinical Alzheimer’s disease research.
-
DAPT (GSI-IX): A Causal Tool for Angiogenesis
2026-08-27
DAPT (GSI-IX) is more than a Notch signaling pathway inhibitor: it is a causal perturbation tool for separating γ-secretase-dependent effects from downstream angiogenic phenotypes. This article translates a critical limb ischemia study into practical assay design, controls, and interpretation strategies.
-
Faropenem Transport via Renal Npt1
2026-08-27
The reference study identified the mouse inorganic phosphate transporter Npt1 as a chloride-sensitive luminal pathway for faropenem transport in renal epithelial cells. Its Xenopus oocyte experiments connect transporter affinity, directional efflux, and β-lactam competition, providing a mechanistic framework for interpreting renal elimination of penem antibiotics.
-
Calcium Modulation of Amyloid-β Aggregation
2026-08-26
The 2024 PCCP study used supercritical-angle Raman and fluorescence spectroscopy and microscopy to examine how CaCl2 changes amyloid-β aggregation at lipid membrane interfaces. Its central finding is that calcium can protect membranes from peptide insertion, while its effect depends on aggregation timing and is more pronounced for Aβ1–42 than for Aβ1–40.
-
Calpain Inhibitor II, ALLM: Mechanism & Uses
2026-08-26
Calpain Inhibitor II, also called ALLM, is a cell-permeable peptide inhibitor for calpain I, calpain II, cathepsin L, and cathepsin B. Its strongest reported affinity is for cathepsin L, while leukemia and lymphoma studies support its use as a concentration-dependent apoptosis inducer and protease biology tool.
-
Aurora A, SAM Metabolism, and Trained Immunity
2026-08-25
Li et al. identify Aurora kinase A as a metabolic–epigenetic regulator of β-glucan-trained immunity, linking the mTOR–FOXO3–GNMT axis to endogenous S-adenosylmethionine availability and inflammatory chromatin states. The study shows that Aurora A inhibition weakens cytokine recall responses and removes the tumor-suppressive effect of trained immunity in mice, providing a mechanistic framework for connecting cancer biology with innate immune memory.